Navitoclax-piperazine, also known as ABT-263-piperazine, is a Navitoclax derative and is a B-cell lymphoma extra large (BCL-XL) inhibitor. Navitoclax-piperazine is a useful material to make PrOTAC agent DT2216.
MedKoo Cat#: 556358
Name: Navitoclax-piperazine
CAS#: 2143096-93-7 (Navitoclax-piperazine)
Chemical Formula: C47H56ClF3N6O5S3
Exact Mass: 972.3115
Molecular Weight: 973.63
Elemental Analysis: C, 57.98; H, 5.80; Cl, 3.64; F, 5.85; N, 8.63; O, 8.22; S, 9.88
The following data is based on the product molecular weight 973.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |